US 10377751
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted A61KA61K31/439A61K31/46
Quick answer
US patent 10377751 (8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/439, A61K31/46, A61K31/485, A61K45/06